Skip to main content

Table 1 Characteristics of case examples for evidence-based practice financing strategies

From: Translating economic evaluations into financing strategies for implementing evidence-based practices

Characteristic

Case 1

Case 2

Case 3

Financing strategies used

Pay-for-Success

Alternative payment models: case management payment, pay-for-performance

Fiscal mapping process (i.e., tailoring of strategies)

Service sector

Behavioral health

Medical/hospital

Primary care

Clinical problem

Serious behavior problems (e.g., conduct disorder)

Cancer

Opioid use disorder

Evidence-based practice(s)

Multisystemic therapy (MST)

24/7 clinician access, patient navigation, comprehensive care plan, guideline-consistent treatment

Integrating Support Persons In Recovery (adapted Community Reinforcement and Family Training)

Service modality

Family- and community-based psychotherapy

Bundle of care coordination and treatment services

Group intervention for support persons; in-person and telehealth versions

Other implementation strategies used

Required readiness, training/consultation, and quality assurance activities

Audit-and-feedback, continuous quality improvement, updated health record systems

Training and ongoing supervision

Evidence base

Extensive clinical and economic effectiveness data

Extensive clinical data and more limited (but still promising) economic data

Original intervention has shown clinical efficacy; adaptation is being evaluated in a pragmatic trial

Stakeholders involved in financing decisions

Colorado Governor’s office; social impact investor companies; MST intermediary

Center for Medicare & Medicaid Services, based on diverse stakeholder input

Bottom-up decision-making: intervention developer conducts fiscal mapping with input from health system and funding agency partners

Role of economic evaluation in financing decisions

Projected cost-savings were the basis of selecting MST for implementation

A simulation budget impact analysis was conducted for the new payment models based on prior studies

Cost data are being collected and evaluated during the pragmatic trial